The largest database of trusted experimental protocols

3 protocols using tgf β1 2 3 neutralizing antibody 1d11

1

Real-time Cell Proliferation Assay for ASCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proliferation of ASCs was measured using the xCelligence real-time cell analyzer system from Roche (Roche Applied Science, Penzberg, Germany, http://www.roche.com). In brief, 800 cells/well of NT, LV-CTRL, LV#3, and LV#6 mASCs or NT, LV-CTRL, LV#18, and LV#19 hASCs were added to 16-well E-plates as described previously 30 (link). The E-plates were then placed on the device station in the incubator (normoxia; 5% CO2 at 37°C) for continuous recording of impedance, as reflected by cell index. In some experiments, a TGF-β1/2/3-neutralizing antibody (1D11; R&D Systems, Minneapolis, MN, http://www.rndsystems.com) or SB431542 (Sigma) was added on days 1 and 3 to the wells at 2.5 µg/ml and 10 µM, respectively. Cell proliferation was also assayed using the CellTiter-Blue reagent, according to the manufacturer's instructions (Promega, Madison, WI, http://www.promega.com). In brief, NT, LV-CTRL, LV#3, and LV#6 mASCs were seeded in 96-well plates (800 cells/well) and cultured at 5% O2/5% CO2 at 37°C. On days 1, 3, and 7, CellTiter-Blue was added to the cells during the last 4 hours of culture and fluorescence was measured at 560 nm on a Glomax multidetection system (Promega).
+ Open protocol
+ Expand
2

C2C12 Myogenic Differentiation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
C2C12 cells (ATCC, Manassas, VA) were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM, Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (Sigma-Aldrich, St. Louis, MO). Differentiation was induced when cells reached approximately 80% confluence by switching to differentiation medium, DMEM supplemented with 2% horse serum (Life Technologies). Cells were treated with growth factors or inhibitors after three days of differentiation. For treatment with the inhibitors ActRIIB-Fc (generously provided by Qian Wang, Stony Brook University Medical Center) and TGF-β1/2/3 neutralizing antibody 1D11 (R&D Systems, Minneapolis, MN), media was changed to DMEM supplemented with 0.1% bovine serum albumin 24 hours before the addition of the inhibitors. For treatment with recombinant myostatin, activin A, TGF-β1 and insulin-like growth factor 1 (IGF-1) (all obtained from R&D Systems), media was changed to DMEM supplemented with 0.1% bovine serum albumin and the indicated growth factor on the third day post differentiation media change. For all treatments, cells were incubated for 5 hours and harvested in TRIzol (Life Technologies) for qRT-PCR analysis.
+ Open protocol
+ Expand
3

C2C12 Cell Differentiation and Growth Factor Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
C2C12 cells (ATCC, Manassas, VA) were maintained in Dulbecco’s Modified Eagle’s Medium (DMEM, Life Technologies, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (Sigma-Aldrich, St. Louis, MO). Differentiation was induced when cells reached approximately 80% confluence by switching to differentiation medium, DMEM supplemented with 2% horse serum (Life Technologies). Cells were treated with growth factors or inhibitors after three days of differentiation. For treatment with the inhibitors ActRIIB-Fc (generously provided by Qian Wang, Stony Brook University Medical Center, produced as previously described [27 ]) and TGF-β1/2/3 neutralizing antibody 1D11 (R&D Systems, Minneapolis, MN), media was changed to DMEM supplemented with 0.1% bovine serum albumin 24 hours before the addition of the inhibitors. For treatment with recombinant myostatin, activin A, TGF-β1 and insulin-like growth factor 1 (IGF-1) (all obtained from R&D Systems), media was changed to DMEM supplemented with 0.1% bovine serum albumin and the indicated growth factor on the third day post differentiation media change. For all treatments, cells were incubated for 5 hours and harvested in TRIzol (Life Technologies) for qRT-PCR analysis.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!